Post-approval studies (Phase 4)Study completedNCT00176982What this trial is testingPlaquenil for Alopecia Areata, Alopecia TotalisWho this might be right forAlopecia Areata Hordinsky, Maria K., MD 16
Not applicableStudy completedNCT05098600What this trial is testingThe Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis+24 more Faculty Hospital Kralovske Vinohrady 123
Testing effectiveness (Phase 2)Study completedNCT02812342What this trial is testingTopical Tofacitinib for the Treatment of Alopecia Areata and Its VariantsWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Yale University 10
Post-approval studies (Phase 4)Study completedNCT01167946What this trial is testingSafety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia AreataWho this might be right forAlopecia TotalisAlopecia UniversalisOphiasic Alopecia King Saud University 42
Large-scale testing (Phase 3)Active Not RecruitingNCT06873945What this trial is testing2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataWho this might be right forAlopecia Areata Pfizer 550
Not applicableLooking for participantsNCT06283316What this trial is testingSystemic Treatments for Alopecia Areata RegistryWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis+5 more Erasmus Medical Center 10,000
Testing effectiveness (Phase 2)Ended earlyNCT04517864What this trial is testingPLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATAWho this might be right forAlopecia Areata Pfizer 71
Testing effectiveness (Phase 2)Study completedNCT02197455What this trial is testingTofacitnib for the Treatment of Alopecia Areata and VariantsWho this might be right forAlopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU) Yale University 30
Not applicableAvailableNCT05522556What this trial is testingPre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Who this might be right forAlopecia Areata Pfizer
Post-approval studies (Phase 4)Study completedNCT03800979What this trial is testingEffectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia AreataWho this might be right forAlopecia Areata Institute of Dermatology, Thailand 19
Testing effectiveness (Phase 2)Study completedNCT03315689What this trial is testingSafety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)Who this might be right forAlopecia Universalis (AU)Alopecia Totalis (AT) Aclaris Therapeutics, Inc. 11
Large-scale testing (Phase 3)Study completedNCT04006457What this trial is testingLong-Term PF-06651600 for the Treatment of Alopecia AreataWho this might be right forAlopecia Areata Pfizer 1,057
Testing effectiveness (Phase 2)Ended earlyNCT02553330What this trial is testingA Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)Who this might be right forAlopecia Areata Incyte Corporation 90
Testing effectiveness (Phase 2)WithdrawnNCT04238091What this trial is testingClinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Lindsey Bordone
Testing effectiveness (Phase 2)Study completedNCT02684097What this trial is testingA Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia AreataWho this might be right forAlopecia Areata Emma Guttman 22
Testing effectiveness (Phase 2)Study completedNCT03594227What this trial is testingATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia TotalisWho this might be right forAlopecia Aclaris Therapeutics, Inc. 87
Not applicableActive Not RecruitingNCT00069589What this trial is testingAlopecia Areata RegistryWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis+2 more M.D. Anderson Cancer Center 3,100
Large-scale testing (Phase 3)Study completedNCT00997815What this trial is testingThe Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia UniversalisWho this might be right forRecalcitrant Alopecia TotalisRecalcitrant Alopecia Universalis Siriraj Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04011748What this trial is testingClinical Application of Stem Cell Educator Therapy in Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Throne Biotechnologies Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02299297What this trial is testingStudy To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And UniversalisWho this might be right forAlopecia Areata Columbia University 12